Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Johnson and Johnson
Daiichi Sankyo
Healthtrust
Queensland Health
Deloitte
Julphar
Fuji
Medtronic

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017851

« Back to Dashboard

NDA 017851 describes LIORESAL, which is a drug marketed by Saol Theraps Res Ltd and Novartis and is included in two NDAs. It is available from two suppliers. Additional details are available on the LIORESAL profile page.

The generic ingredient in LIORESAL is baclofen. There are nineteen drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the baclofen profile page.
Summary for 017851
Tradename:LIORESAL
Applicant:Novartis
Ingredient:baclofen
Patents:0
Therapeutic Class:Antispasticity Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017851

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jan 20, 1982TE:RLD:Yes

Expired US Patents for NDA 017851

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LIORESAL baclofen TABLET;ORAL 017851-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis LIORESAL baclofen TABLET;ORAL 017851-003 Jan 20, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Fish and Richardson
Cerilliant
Queensland Health
Daiichi Sankyo
Teva
Federal Trade Commission
Boehringer Ingelheim
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.